Effects of retroviral-mediated MDR1 expression on hematopoietic stem cell self-renewal and differentiation in culture

Annals of the New York Academy of Sciences

Volumn 872, Issue , 1999, Pages 125-141

  Bunting, Kevin D ^a   Galipeau, Jacques ^a   Topham, David ^a   Benaim, Ely ^a   Sorrentino, Brian P ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DIHYDROFOLATE REDUCTASE; INTERLEUKIN 3; INTERLEUKIN 6; MULTIDRUG RESISTANCE PROTEIN; STEM CELL FACTOR; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; BONE MARROW TRANSPLANTATION; CELL CULTURE; CELL DAMAGE; CELL DIFFERENTIATION; CELL RENEWAL; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; FLOW CYTOMETRY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; LEUKOCYTE; LEUKOCYTE COUNT; MOUSE; MULTIDRUG RESISTANCE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; RETROVIRUS; RIBOSOME; STEM CELL TRANSPLANTATION;

ANIMALIA; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0033000185     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08459.x     Document Type: Conference Paper

References (50)

1. MORRISON, S.J. & I.L. WEISSMAN. 1994. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1: 661-673.
2. HARRISON, D.E., C.M. ASTLE & C. LERNER. 1988. Number and continuous proliferative pattern of transplanted primitive immunohematopoietic stem cells. Proc. Natl. Acad. Sci. USA 85: 822-826.
3. HAO, Q.L., A.J. SHAH, F.T. THIEMANN, E.M. SMOGORZEWSKA & G.M. CROOKS. 1995. A functional comparison of CD34+CD38-cells in cord blood and bone marrow. Blood 86: 3745-3753.
4. BERARDI, A.C., A. WANG, J.D. LEVINE, P. LOPEZ & D.T. SCADDEN. 1995. Functional isolation and characterization of human hematopoietic stem cells. Science 267: 104-108.
5. LERNER, C. & D.E. HARRISON. 1990. 5-Fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp. Hematol. 18: 114-118.
6. -) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. J. Exp. Med. 183: 2551-2558.
7. ORLIC, D. & D.M. BODINE. 1994. What defines a pluripotent hematopoietic stem cell (PHSC): will the real PHSC please stand up! Blood 84: 3991-3994.
8. LAROCHELLE, A., J. VORMOOR, H. HANENBERG, J.C. WANG, M. BHATIA, T. LAPIDOT, T. MORITZ, B. MURDOCH, X.L. XIAO, I. KATO, D.A. WILLIAMS & J.E. DICK. 1996. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat. Med. 2: 1329-1337.
9. NOLTA, J.A., M.B. HANLEY & D.B. KOHN. 1994. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood 83: 3041-3051.
10. NAMIKAWA, R., K.N. WEILBAECHER, H. KANESHIMA, E.J. YEE & J.M. MCCUNE. 1990. Long-term human hematopoiesis in the SCID-hu mouse. J. Exp. Med. 172: 1055-1063.
11. CASHMAN, J.D., T. LAPIDOT, J.C. WANG, M. DOEDENS, L.D. SHULTZ, P. LANSDORP, J.E. DICK & C.J. EAVES. 1997. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood 89: 4307-4316.
12. SMITH, L.G., I.L. WEISSMAN & S. HEIMFELD. 1991. Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc. Natl. Acad. ci. USA 88: 2788-2792.
13. HARRISON, D.E. & C.P. LERNER. 1991. Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. Blood 78: 1237-1240.
14. BODINE, D.M., K.T. MCDONAGH, N.E. SEIDEL & A.W. NIENHUIS. 1991. Survival and retrovirus infection of murine hematopoictic stem cells in vitro: effects of 5-FU and method of infection. Exp. Hematol. 19: 206-212.
15. BODINE, D.M., S. KARLSSON & A.W. NIENHUIS. 1989. Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 86: 8897-8901.
16. BODINE, D.M., D. ORLIC, N.C. BIRKETT, N.E. SEIDEL, & K.M. ZSEBO. 1992. Stem cell factor increases colony-forming unit-spleen number in vitro in synergy with interleukin-6, and in vivo in Sl/Sld mice as a single factor. Blood 79: 913-919.
17. LUSKEY, B.D., M. ROSENBLATT, K. ZSEBO & D.A. WILLIAMS. 1992. Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood 80: 396-402.
18. MILLER, C.L. & C.J. EAVES. 1997. Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability. Proc. Natl. Acad. Sci. USA 94: 13648-13653.
19. PETERS, S.O., E.L. KITTLER, H.S. RAMSHAW & P.J. QUESENBERRY. 1996. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 87: 30-37.
20. TRAYCOFF, C.M., K. CORNETTA, M.C. YODER, A, DAVIDSON & E.F. SROUR. 1996. Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential. Exp. Hematol. 24: 299-306.
21. WILLIAMS, D.A. 1993. Ex vivo expansion of hematopoietic stem and progenitor cells - robbing Peter to pay Paul? Blood 81: 3169-3172.
22. + cells. Exp. Hematol. 26: 53-62.
23. BUNTING, K.D., J. GALIPEAU, D. TOPHAM, E. BENAIM & B.P. SORRENTINO. 1998. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood 92: 2269-2279
24. GALIPEAU, J., E. BENAIM, H.T. SPENCER, R.L. BLAKLEY & B.P. SORRENTINO. 1997. A bicistronic retroviral vector for protecting hematopoietic cells against antifolates and P-glycoprotein effluxed drugs. Hum. Gene Ther. 8: 1773-1783.
25. SPENCER, H.T., S.E. SLEEP, J.E. REHG, R.L. BLAKLEY & B.P. SORRENTINO. 1996. A gene transfer strategy for making bone marrow cells resistant to trimetrexate. Blood 87: 2579-2587.
26. SORRENTINO, B.P., K.T. MCDONAGH, D. WOODS & D. ORLIC. 1995. Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood 86: 491-501.
27. MARKOWITZ, D., S. GOFF & A. BANK. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62: 1120-1124.
28. ALLAY, J.A., H.T. SPENCER, S.L. WILKINSON, J.A. BELT, R.L. BLAKLEY & B.P. SORRENTINO. 1997. Sensitization of hematopoietic stem and progenitor cells to trimetrexate using nucleoside transport inhibitors. Blood 90: 3546-3554.
29. SPANGRUDE, G.J., S. HEIMFELD & I.L. WEISSMAN. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241: 58-62.
30. ORLIC, D., R. FISCHER, S. NISHIKAWA, A.W. NIENHUIS & D.M. BODINE. 1993. Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. Blood 82: 762-770.
31. SPANGRUDE, G.J. & G.R. JOHNSON. 1990. Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 87: 7433-7437.
32. ZIJLMANS, J.M., J.W. VISSER, K. KLEIVERDA, P.M. KLUIN, R. WILLEMZE & W.E. FIBBE. 1995. Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability. Proc. Natl. Acad. Sci. USA 92: 8901-8905.
33. UCHIDA, N., J. COMBS, S. CHEN, E, ZANJANI, R. HOFFMAN & A. TSUKAMOTO. 1996. Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities. Blood 88: 1297-1305.
34. CHAUDHARY, P.M. & I.B. RONINSON. 1991. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66: 85-94.
35. GOODELL, M.A., K. BROSE, G. PARADIS, A.S. CONNER & R.C. MULLIGAN. 1996. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183: 1797-1806.
36. SPANGRUDE, G.J., D.M. BROOKS & D.B. TUMAS. 1995. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. Blood 85: 1006-1016.
37. SCHINKEL, A.H., U. MAYER, E. WAGENAAR, C.A. MOL, L. van DEEMTER, J.J. SMIT, M.A. VAN DER VALK, A.C. VOORDOUW, H. SPITS, O. VAN TELLINGEN, J.M. ZIJLMANS, W.E. FIBBE & P. BORST. 1997. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA 94: 4028-4033.
38. GROS, P., R. DHIR, J. CROOP & F. TALBOT. 1991. A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps. Proc. Natl. Acad. Sci. USA 88: 7289-7293.
39. RONINSON, I.B., J.E. CHIN, K.G. CHOI, P. GROS, D.E. HOUSMAN, A. FOJO, D.W. SHEN, M.M. GOTTESMAN & I. PASTAN. 1986. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc. Natl. Acad. Sci. USA 83: 4538-4542.
40. SCHINKEL, A.H. & P. BORST. 1991. Multidrug resistance mediated by P-glycoproteins. Sem. Cancer Biol. 2: 213-226.
41. BORST, P. 1991. Genetic mechanisms of drug resistance. A review. Acta Oncol. 30: 87-105.
42. VAN HELVOORT, A., A.J. SMITH, H. SPRONG, I. FRITZSCHE, A.H. SCHINKEL, P. BORST & G. van MEER. 1996. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87: 507-517.
43. MARTIN, S.J., D.M. FINUCANE, G.P. AMARANTE-MENDES, G.A, O'BRIEN & D.R. GREEN. 1996. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J. Biol. Chem. 271: 28753-28756.
44. MARTIN, S.J., C.P. REUTELINGSPERGER, A.J. MCGAHON, J.A. RADER, R.C. van SCHIE, D.M. LAFACE & D.R. GREEN. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182: 1545-1556.
45. HANNUN, Y.A. & L.M. OBEID. 1997. Mechanisms of ceramide-mediated apoptosis. Adv. Exp. Med. Biol. 407: 145-149.
46. BEZOMBES, C., N. MAESTRE, G. LAURENT, T. LEVADE, A. BETTAIEB & J.P. JAFFREZOU. 1998. Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833. FASEB J. 12: 101-109.
47. ROBINSON, L.J., W.K. ROBERTS, T.T. LING, D. LAMMING, S.S. STERNBERG & P.D. ROEPE. 1997. Human MDR 1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts. Biochemistry 36: 11169-11178.
48. PODDA, S., M. WARD, A. HIMELSTEIN, C. RICHARDSON, E. DE LA FLOR-WEISS, L. SMITH, M. GOTTESMAN, I. PASTAN & A. BANK. 1992. Transfer and expression of the human multiple drug resistance gene into live mice. Proc. Natl. Acad. Sci. USA 89: 9676-9680.
49. + cells. Blood 84: 1408-1414.
50. HANANIA, E.G. & A.B. DEISSEROTH. 1994. Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model. Cancer Gene Ther. 1: 21-25.